A new lung CT analysis technique, parametric response mapping, can help distinguish between early-stage damage and more serious damage to the airway.
A new technique called parametric response mapping used to analyze lung CT scans can help physicians distinguish between early-stage damage to the airway and emphysema, according to a study published online in Nature Medicine. The PRM technique was originally developed to show a response of brain tumors to treatment.
“Essentially, with the PRM technique, we’ve been able to tell sub-types of COPD apart, distinguishing functional small airway disease or fSAD from emphysema and normal lung function,” Brian Ross, PhD, said in a release. Ross is a professor of radiology and biological chemistry at the University of Michigan Medical School, and the paper’s senior author.
Researchers assessed 194 patients selected from the much larger COPDGene study. The patients had at least a 10-pack-year history of smoking. All CT data were obtained and analysis was performed as part of the COPDGene project.
The researchers used the computer techniques to overlay the CT scan image, taken during a full inhalation, with an image that was taken during full exhalation. Using the images, the researchers created a three-dimensional map of the lungs. The density of healthy lung tissue will change more between the two images than that of diseased lung tissue.
PRM assigns colors to each small 3-D area, called a voxel, according to the difference in signal changes between the two scans. Green means healthy, yellow means a reduced ability to push air out of the small sacs, and red means severely reduced ability, researchers said.
Spirometry is still considered the best test for diagnosing COPD, but researchers said it is limited in its ability to distinguish between different types of lung damage COPD patients experience.
By repeating the imaging over time, it would be possible to track COPD progression, said lead author Craig Gabán, assistant professor of radiology. More studies need to be done to see if this would be an effective approach.
From left to right, PRM images of the lungs of a healthy person, two people with mild to moderate COPD, and a person with severe emphysema. Green is healthy tissue, yellow is small airway damage, and red is more severe damage. Images courtesy the Center for Molecular Imaging, University of Michigan.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.